Professor, NCIC Clinical Trials
|Biostatistics, clinical trials, longitudinal data, resampling methods, survival analysis
Degrees & Accolades:
Ph.D. (Medical University of South Carolina)
I am a Senior Biostatistician in the Canadian Cancer Trials Group with appointments in both the Departments of Community Health & Epidemiology, and Mathematics & Statistics. My primary responsibilities are the design, management and analysis of the cancer clinical trials. I am also interested in the methodological research on the development and evaluation of statistical procedures for the design and analysis of cancer clinical trials.
Research on the cause, detection, prevention and treatment of cancer is one of the most active research areas in the health sciences. Clinical trials are key component in the development of new drugs or procedures to treat the cancer or prevent the development of the cancer. Statistical methods play a pivotal role in the design and analysis of cancer clinical trials. Because of rapid progress in the understanding of cancer biology, many new drugs and treatment procedures have been developed in the recent years. New statistical methods are required to make the clinical trials evaluating these drugs and procedures more accurate and efficient. Development and evaluation of these new statistical methods with applications to the clinical trials conducted by the Canadian Cancer Trials Group has been the primary topic of my research program in statistics.